Prevention of coronary artery disease in cancer patients

Improvements in cancer treatment are increasing survival rates, placing cancer survivors at increased risk of coronary artery disease (CAD). Thoracic radiation as cancer therapy can accelerate the atherosclerotic process, and some older studies suggest that mediastinal radiation can increase the CAD risk two to fivefold. The management of serum lipids using diet and drugs is the cornerstone of efforts designed to reduce CAD events. The present article reviews the association between radiation and coronary disease and provides guidelines for the prevention of atherosclerotic CAD in this patient group and in the general population of cancer survivors. Pediatr Blood Cancer 2005;44:620–624. © 2005 Wiley‐Liss, Inc.

[1]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[2]  Paul Schoenhagen,et al.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.

[3]  Thomas Weber,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[4]  C. Pepine,et al.  Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.

[5]  M. Theodoulou,et al.  Cardiac effects of adjuvant therapy for early breast cancer. , 2003, Seminars in oncology.

[6]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[7]  T. Crosby,et al.  The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[9]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[10]  P. Douglas,et al.  Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[12]  J. Beckman,et al.  Radiation therapy impairs endothelium-dependent vasodilation in humans. , 2001, Journal of the American College of Cardiology.

[13]  E. Gong,et al.  Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[14]  P. Levendag,et al.  Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  W. Mackillop,et al.  Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[17]  J. Manola,et al.  No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Mike Clarke,et al.  EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .

[19]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[20]  J. R. Stewart,et al.  Radiation injury to the heart. , 1995, International journal of radiation oncology, biology, physics.

[21]  S L Hancock,et al.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.

[22]  J. Silber,et al.  Cardiac dysfunction following spinal irradiation during childhood. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  I. Lax,et al.  Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[24]  L. Rutqvist,et al.  Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. , 1990, British Journal of Cancer.